Outcome of Patients with Chronic Myeloid Leukemia After Allogeneic Stem Cell Transplantation in Europe; Data From the EUTOS for CML Registry

被引：0

作者：

Saussele, Susanne ^{[1
]}

Hoffmann, Verena ^{[2
]}

Lindoerfer, Doris ^{[2
]}

Hochhaus, Andreas ^{[3
]}

Cervantes, Francisco ^{[4
]}

Ossenkoppele, Gert ^{[5
]}

Hjorth-Hansen, Henrik ^{[6
]}

O'Brien, Steve ^{[7
]}

Mayer, Jiri ^{[8
]}

Indrak, Karel ^{[9
]}

Hellmann, Andrzej ^{[10
]}

Colita, Adriana

Turkina, Anna ^{[11
]}

Zaritskey, Andrey ^{[12
]}

Luis Steegmann, Juan ^{[13
]}

Marin, David ^{[14
]}

Pfirrmann, Markus ^{[2
]}

Baccarani, Michele ^{[15
]}

Guilhot, Joelle ^{[16
]}

Hasford, Joerg ^{[2
]}

Piccolo, Carmen ^{[17
]}

Simonsson, Bengt ^{[18
]}

Hehlmann, Ruediger ^{[1
]}

Rosti, Gianantonio ^{[19
]}

机构：

[1] Univ Heidelberg, Med Fak Mannheim, Med Klin 3, D-6800 Mannheim, Germany

[2] Univ Munich, Inst Med Informat & Biometry, Munich, Germany

[3] Univ Klinikum Jena, Jena, Germany

[4] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain

[5] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[6] Norwegian Univ Sci & Technol, Trondheim, Norway

[7] Newcastle Univ, Dept Hematol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[8] Univ Hosp Brno, Dept Haematol Oncol, Brno, Czech Republic

[9] Univ Hosp, Dept Hematooncol, Olomouc, Czech Republic

[10] Med Univ Gdansk, Dept Hematol & Transplantol, Gdansk, Poland

[11] Natl Res Ctr Hematol, Moscow, Russia

[12] VA Almazov, Ctr Heart Blood & Endocrinol, St Petersburg, Russia

[13] Hosp Univ Princesa, Dept Hematol, Madrid, Spain

[14] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Hematol, London, England

[15] Univ Bologna, Dept Hematol Oncol L&A Seragnoli, Bologna, Italy

[16] CHU Poitiers, INSERM, CIC 0802, Poitiers, France

[17] Novartis GmbH, Origgio, Italy

[18] Univ Uppsala Hosp, Dept Med, Uppsala, Sweden

[19] Univ Bologna, Dept Hematol & Oncol L&A Seragnoli, Bologna, Italy

来源：

BLOOD | 2011年 / 118卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：733 / 734

页数：2

共 50 条

[31] Allogeneic stem cell transplantation for chronic myeloid leukemia–status in 2007
J M Goldman
Bone Marrow Transplantation, 2008, 42 : S11 - S13
[32] Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives
Bacigalupo, Andrea
CURRENT CANCER DRUG TARGETS, 2013, 13 (07) : 775 - 778
[33] Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML
Christian Niederwieser
Elena Morozova
Ludmila Zubarovskaya
Tatjana Zabelina
Evgeny Klyuchnikov
Dietlinde Janson
Christine Wolschke
Maximilian Christopeit
Francis Ayuk
Ivan Moiseev
Boris V. Afanasyev
Nicolaus Kröger
Bone Marrow Transplantation, 2021, 56 : 2834 - 2841
[34] Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML
Niederwieser, Christian
Morozova, Elena
Zubarovskaya, Ludmila
Zabelina, Tatjana
Klyuchnikov, Evgeny
Janson, Dietlinde
Wolschke, Christine
Christopeit, Maximilian
Ayuk, Francis
Moiseev, Ivan
Afanasyev, Boris V.
Kroger, Nicolaus
BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2834 - 2841
[35] Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation
Ocheni, Sunday
Iwanski, Gabriela B.
Schafhausen, Philippe
Zander, Axel Rolf
Ayuk, Francis
Klyuchnikov, Evgeny
Zabelina, Tatjana
Fiedler, Walter
Schnittger, Susanne
Hochhaus, Andreas
Bruemmendorf, Tim H.
Kroeger, Nicolaus
Bacher, Ulrike
LEUKEMIA & LYMPHOMA, 2009, 50 (04) : 551 - 558
[36] Significance of Minimal Residual Disease in Patients with Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
Solarska, Iwona
Nasilowska-Adamska, Barbara
Bieniaszewska, Maria
Zaucha, Jan Maciej
Rzepecki, Piotr
Sawicki, Waldemar
Calbecka, Malgorzata
Lech-Maranda, Ewa
Marianska, Bozena
Warzocha, Krzysztof
BLOOD, 2009, 114 (22) : 1266 - 1266
[37] Allogeneic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia After Prior Treatment with Nilotinib or Dasatinib.
Schleuning, Michael
Scholten, Marijke
van Biezen, Anja
Nagler, Arnon
Apperley, Jane F.
Michallet, Mauricette
Grigg, Andrew
Silver, Richard T.
Leitner, Armin
Gratwohl, Alois
Ekblom, Maria
Khoury, H. Jean
de Witte, Theo
Olavarria, Eduardo
BLOOD, 2010, 116 (21) : 970 - 970
[38] Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia
Devillier, Raynier
Crocchiolo, Roberto
Etienne, Anne
Prebet, Thomas
Charbonnier, Aude
Fuerst, Sabine
El-Cheikh, Jean
D'Incan, Evelyne
Rey, Jerome
Faucher, Catherine
Blaise, Didier
Vey, Norbert
LEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1228 - 1234
[39] Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)?
Sora, Federica
Chiusolo, Patrizia
Autore, Francesco
Giammarco, Sabrina
Laurenti, Luca
Metafuni, Elisabetta
Innocenti, Idanna
Galli, Eugenio
Bacigalupo, Andrea
Sica, Simona
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2021, 13
[40] Allogeneic hematopoietic stem cell transplantation (HSCT) for chronic myeloid leukemia (CML) patients in the TKI-era: A single center experience
Schmidt, E.
Groth, C.
Mikesch, J. -H.
Reicherts, C.
Mesters, R.
Schliemann, C.
Kessler, T.
Kerkhoff, A.
Kropff, M.
Lenz, G.
Berdel, W. E.
Stelljes, M.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 144 - 144

← 1 2 3 4 5 →